149 related articles for article (PubMed ID: 27603373)
1. First case report of an adrenocortical carcinoma caused by a BRCA2 mutation.
El Ghorayeb N; Grunenwald S; Nolet S; Primeau V; Côté S; Maugard CM; Lacroix A; Gaboury L; Bourdeau I
Medicine (Baltimore); 2016 Sep; 95(36):e4756. PubMed ID: 27603373
[TBL] [Abstract][Full Text] [Related]
2. TP53 germline mutations in adult patients with adrenocortical carcinoma.
Herrmann LJ; Heinze B; Fassnacht M; Willenberg HS; Quinkler M; Reisch N; Zink M; Allolio B; Hahner S
J Clin Endocrinol Metab; 2012 Mar; 97(3):E476-85. PubMed ID: 22170717
[TBL] [Abstract][Full Text] [Related]
3. Diseases Predisposing to Adrenocortical Malignancy (Li-Fraumeni Syndrome, Beckwith-Wiedemann Syndrome, and Carney Complex).
Jouinot A; Bertherat J
Exp Suppl; 2019; 111():149-169. PubMed ID: 31588532
[TBL] [Abstract][Full Text] [Related]
4. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.
Giacomazzi J; Selistre SG; Rossi C; Alemar B; Santos-Silva P; Pereira FS; Netto CB; Cossio SL; Roth DE; Brunetto AL; Zagonel-Oliveira M; Martel-Planche G; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P
Cancer; 2013 Dec; 119(24):4341-9. PubMed ID: 24122735
[TBL] [Abstract][Full Text] [Related]
5. Novel germline mutation of the p53 tumor suppressor gene in a child with incidentally discovered adrenal cortical carcinoma.
Grayson GH; Moore S; Schneider BG; Saldivar V; Hensel CH
Am J Pediatr Hematol Oncol; 1994 Nov; 16(4):341-7. PubMed ID: 7978053
[TBL] [Abstract][Full Text] [Related]
6. Adrenocortical carcinoma and succinate dehydrogenase gene mutations: an observational case series.
Else T; Lerario AM; Everett J; Haymon L; Wham D; Mullane M; Wilson TL; Rainville I; Rana H; Worth AJ; Snyder NW; Blair IA; McKay R; Kilbridge K; Hammer G; Barletta J; Vaidya A
Eur J Endocrinol; 2017 Nov; 177(5):439-444. PubMed ID: 28819017
[TBL] [Abstract][Full Text] [Related]
7. Adrenocortical carcinoma (ACC): When and why should we consider germline testing?
Petr EJ; Else T
Presse Med; 2018; 47(7-8 Pt 2):e119-e125. PubMed ID: 30104051
[TBL] [Abstract][Full Text] [Related]
8. Composite Adrenocortical Carcinoma and Neuroblastoma in an Infant With a TP53 Germline Mutation: A Case Report and Literature Review.
Tang YJ; Yu TT; Ma J; Zhou Y; Xu M; Gao YJ
J Pediatr Hematol Oncol; 2019 Jul; 41(5):399-401. PubMed ID: 29746440
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: a children's oncology group study.
Wasserman JD; Novokmet A; Eichler-Jonsson C; Ribeiro RC; Rodriguez-Galindo C; Zambetti GP; Malkin D
J Clin Oncol; 2015 Feb; 33(6):602-9. PubMed ID: 25584008
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of germline TP53 mutations in a prospective series of unselected patients with adrenocortical carcinoma.
Raymond VM; Else T; Everett JN; Long JM; Gruber SB; Hammer GD
J Clin Endocrinol Metab; 2013 Jan; 98(1):E119-25. PubMed ID: 23175693
[TBL] [Abstract][Full Text] [Related]
11. Pediatric adrenocortical carcinoma.
Ilanchezhian M; Varghese DG; Glod JW; Reilly KM; Widemann BC; Pommier Y; Kaplan RN; Del Rivero J
Front Endocrinol (Lausanne); 2022; 13():961650. PubMed ID: 36387865
[TBL] [Abstract][Full Text] [Related]
12. Combined steroidogenic characters of fetal adrenal and Leydig cells in childhood adrenocortical carcinoma.
Fujisawa Y; Sakaguchi K; Ono H; Yamaguchi R; Kato F; Kagami M; Fukami M; Ogata T
J Steroid Biochem Mol Biol; 2016 May; 159():86-93. PubMed ID: 26940356
[TBL] [Abstract][Full Text] [Related]
13. Clinical spectrum of Li-Fraumeni syndrome/Li-Fraumeni-like syndrome in Brazilian individuals with the TP53 p.R337H mutation.
Ferreira AM; Brondani VB; Helena VP; Charchar HLS; Zerbini MCN; Leite LAS; Hoff AO; Latronico AC; Mendonca BB; Diz MDPE; de Almeida MQ; Fragoso MCBV
J Steroid Biochem Mol Biol; 2019 Jun; 190():250-255. PubMed ID: 30974190
[TBL] [Abstract][Full Text] [Related]
14. Genomic and Clinical Correlates of Adrenocortical Carcinoma in an Adult Patient with Li-Fraumeni Syndrome: A Case Report.
Bondy S; Tajzler C; Hotte SJ; Kapoor A; Zbuk K; Lalani AA
Curr Oncol; 2020 Dec; 28(1):226-232. PubMed ID: 33704190
[TBL] [Abstract][Full Text] [Related]
15. A novel p.Gly187Arg TP53 variant appears to result in Li-Fraumeni syndrome.
Doyle MR; Johnston JM
Pediatr Hematol Oncol; 2018 Apr; 35(3):203-207. PubMed ID: 30239254
[TBL] [Abstract][Full Text] [Related]
16. High frequency of germline p53 mutations in childhood adrenocortical cancer.
Wagner J; Portwine C; Rabin K; Leclerc JM; Narod SA; Malkin D
J Natl Cancer Inst; 1994 Nov; 86(22):1707-10. PubMed ID: 7966399
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel TP53 germline mutation E285V in a rare case of paediatric adrenocortical carcinoma and choroid plexus carcinoma.
Russell-Swetek A; West AN; Mintern JE; Jenkins J; Rodriguez-Galindo C; Ribeiro R; Zambetti GP
J Med Genet; 2008 Sep; 45(9):603-6. PubMed ID: 18762572
[TBL] [Abstract][Full Text] [Related]
18. Whole-exome analysis of a Li-Fraumeni family trio with a novel TP53 PRD mutation and anticipation profile.
Franceschi S; Spugnesi L; Aretini P; Lessi F; Scarpitta R; Galli A; Congregati C; Caligo MA; Mazzanti CM
Carcinogenesis; 2017 Sep; 38(9):938-943. PubMed ID: 28911001
[TBL] [Abstract][Full Text] [Related]
19. [Identification of a novel TP53 germline mutation in one child with adrenocortical carcinoma].
Si N; Sun M; Lu CX; Liu YS; Qi Z; Yang W; Zhao XL; Zhang X
Zhonghua Yi Xue Za Zhi; 2009 May; 89(20):1402-4. PubMed ID: 19671334
[TBL] [Abstract][Full Text] [Related]
20. p53 signaling pathway polymorphisms, cancer risk and tumor phenotype in TP53 R337H mutation carriers.
Macedo GS; Vieira IA; Vianna FSL; Alemar B; Giacomazzi J; Brandalize APC; Caleffi M; Volc SM; de Campos Reis Galvão H; Palmero EI; Achatz MI; Ashton-Prolla P
Fam Cancer; 2018 Apr; 17(2):269-274. PubMed ID: 28756477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]